J. Eaton

The immunotherapy of prostate cancer

R. Kirby, D. Hrouda, M. Perry, 2000, Prostate Cancer and Prostatic Diseases.

Allogeneic whole‐cell vaccine: a phase I/II study in men with hormone‐refractory prostate cancer

M. Perry, R. Kirby, S. Nicholson, 2002, BJU international.

Genetic prodrug activation therapy (GPAT) in two rat prostate models generates an immune bystander effect and can be monitored by magnetic resonance techniques

J. Griffiths, R. Mazucco, A. Dalgleish, 2001, Gene Therapy.

Coxsackie B and adenovirus receptor, integrin and major histocompatibility complex class I expression in human prostate cancer cell lines: implications for gene therapy strategies

H. Pandha, G. Blair, S. Todryk, 2003, Prostate Cancer and Prostatic Diseases.